Company / Inventory per Share
Jazz Pharmaceuticals Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$6.88
FY2025
5-year range
$6.88 / $19.10
FY2021-FY2025
Trend
-10.9%
vs FY2024
Sector context
#9 of 105
Health Care
What the data says
Among 105 Health Care companies, Jazz Pharmaceuticals is in the top 9% for inventory per share. Inventory per Share has declined for 4 consecutive years, from $19.10 in FY2021 to $6.88 in FY2025.
Based on SEC 10-K filings.
6.88 in FY2025 with a 5-year CAGR of +32.3%. Top quartile in the Health Care sector.
Declined from $9.44 to $6.88 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- -16.0%
- 5-Year CAGR
- +32.3%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 105This company $6.88 Sector average $30.82
▼
-77.7% below sector average
Key checks
Key Insights
- Jazz Pharmaceuticals's inventory per share has declined for 4 consecutive years.
- In FY2025, inventory per share decreased 10.9% year-over-year.
- Ranks #9 out of 105 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.88 | -10.9% |
| FY2024 | $7.72 | -18.3% |
| FY2023 | $9.44 | -18.5% |
| FY2022 | $11.59 | -39.3% |
| FY2021 | $19.10 | +1023.9% |
| FY2020 | $1.70 | +24.7% |
| FY2019 | $1.36 | +51.5% |
| FY2018 | $0.90 | +24.4% |
| FY2017 | $0.72 | +30.2% |
| FY2016 | $0.56 | +73.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026